ETF Holdings Breakdown of HAE

Stock NameHaemonetics Corporation
TickerHAE(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS4050241003
LEI549300ZEL6TXZS6F5F95

News associated with HAE

Stifel Financial Corp Grows Position in Haemonetics Co. (NYSE:HAE)
Stifel Financial Corp lifted its position in Haemonetics Co. (NYSE:HAE – Free Report) by 7.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 14,776 shares of the medical instruments supplier’s stock after purchasing an additional 1,006 shares during the quarter. Stifel […] - 2025-05-09 08:26:56
Analysts Set Haemonetics Co. (NYSE:HAE) Price Target at $101.22
Haemonetics Co. (NYSE:HAE – Get Free Report) has received an average recommendation of “Moderate Buy” from the nine research firms that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation, six have given a buy recommendation and one has issued […] - 2025-04-28 05:39:01
Envestnet Asset Management Inc. Buys 4,217 Shares of Haemonetics Co. (NYSE:HAE)
Envestnet Asset Management Inc. boosted its stake in Haemonetics Co. (NYSE:HAE – Free Report) by 9.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 48,068 shares of the medical instruments supplier’s stock after purchasing an additional 4,217 shares during the […] - 2025-04-25 07:40:56
Bank of Montreal Can Sells 12,518,398 Shares of Haemonetics Co. (NYSE:HAE)
Bank of Montreal Can decreased its stake in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 99.9% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 7,933 shares of the medical instruments supplier’s stock after selling 12,518,398 shares during the quarter. Bank of Montreal Can’s holdings in Haemonetics were worth $619,000 as of […] - 2025-04-21 08:18:52
Federated Hermes Inc. Trims Holdings in Haemonetics Co. (NYSE:HAE)
Federated Hermes Inc. reduced its holdings in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 10.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 3,554 shares of the medical instruments supplier’s stock after selling 436 shares during the period. Federated Hermes Inc.’s holdings in Haemonetics […] - 2025-04-18 07:59:07
Haemonetics Co. (NYSE:HAE) Holdings Raised by Pictet Asset Management Holding SA
Pictet Asset Management Holding SA lifted its position in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 16.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,963 shares of the medical instruments supplier’s stock after acquiring an additional 979 […] - 2025-04-09 08:42:56
KLP Kapitalforvaltning AS Makes New Investment in Haemonetics Co. (NYSE:HAE)
KLP Kapitalforvaltning AS acquired a new stake in Haemonetics Co. (NYSE:HAE – Free Report) during the 4th quarter, Holdings Channel.com reports. The fund acquired 10,100 shares of the medical instruments supplier’s stock, valued at approximately $789,000. A number of other hedge funds also recently modified their holdings of HAE. Wellington Management Group LLP raised its […] - 2025-04-01 08:14:58
15,294 Shares in Haemonetics Co. (NYSE:HAE) Bought by Natixis Advisors LLC
Natixis Advisors LLC acquired a new stake in shares of Haemonetics Co. (NYSE:HAE – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund acquired 15,294 shares of the medical instruments supplier’s stock, valued at approximately $1,194,000. A number of other hedge funds have also recently modified their holdings of HAE. Parkside Financial Bank […] - 2025-03-26 07:54:45
Zurcher Kantonalbank Zurich Cantonalbank Acquires 1,202 Shares of Haemonetics Co. (NYSE:HAE)
Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in Haemonetics Co. (NYSE:HAE – Free Report) by 10.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 12,460 shares of the medical instruments supplier’s stock after acquiring an additional 1,202 shares during the period. Zurcher […] - 2025-03-21 08:08:54
Needham & Company LLC Has Lowered Expectations for Haemonetics (NYSE:HAE) Stock Price
Haemonetics (NYSE:HAE – Get Free Report) had its target price cut by stock analysts at Needham & Company LLC from $108.00 to $104.00 in a report issued on Tuesday, Marketbeat reports. The brokerage currently has a “buy” rating on the medical instruments supplier’s stock. Needham & Company LLC’s target price indicates a potential upside of […] - 2025-03-20 06:28:54
Haemonetics Co. (NYSE:HAE) Shares Bought by AlphaQuest LLC
AlphaQuest LLC boosted its position in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 36,520.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 1,831 shares of the medical instruments supplier’s stock after acquiring an additional 1,826 shares during the quarter. AlphaQuest LLC’s holdings […] - 2025-03-18 08:06:52
Haemonetics Co. (NYSE:HAE) Shares Sold by State of Michigan Retirement System
State of Michigan Retirement System decreased its stake in Haemonetics Co. (NYSE:HAE – Free Report) by 2.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,874 shares of the medical instruments supplier’s stock after selling 300 shares during the period. State […] - 2025-03-10 07:41:06
Principal Financial Group Inc. Has $12.24 Million Stock Position in Haemonetics Co. (NYSE:HAE)
Principal Financial Group Inc. grew its holdings in Haemonetics Co. (NYSE:HAE – Free Report) by 1.0% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 156,734 shares of the medical instruments supplier’s stock after acquiring an additional 1,475 shares during the period. Principal Financial Group Inc.’s holdings in Haemonetics were worth $12,238,000 as of […] - 2025-02-28 08:28:49
Haemonetics Co. (NYSE:HAE) Shares Sold by State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D reduced its stake in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 4.6% in the 4th quarter, Holdings Channel.com reports. The fund owned 24,746 shares of the medical instruments supplier’s stock after selling 1,186 shares during the quarter. State of New Jersey Common Pension Fund D’s […] - 2025-02-25 08:38:55
Rhumbline Advisers Acquires 1,024 Shares of Haemonetics Co. (NYSE:HAE)
Rhumbline Advisers increased its holdings in Haemonetics Co. (NYSE:HAE – Free Report) by 0.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 159,262 shares of the medical instruments supplier’s stock after acquiring an additional 1,024 shares during the […] - 2025-02-24 08:33:05
Vontobel Holding Ltd. Acquires 8,133 Shares of Haemonetics Co. (NYSE:HAE)
Vontobel Holding Ltd. boosted its holdings in Haemonetics Co. (NYSE:HAE – Free Report) by 166.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 13,011 shares of the medical instruments supplier’s stock after acquiring an additional 8,133 shares during the period. Vontobel […] - 2025-02-19 08:52:47
StockNews.com Downgrades Haemonetics (NYSE:HAE) to Hold
Haemonetics (NYSE:HAE – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Saturday. Several other research firms have also recently issued reports on HAE. Raymond James reiterated a “strong-buy” rating and issued a $115.00 price objective (down from $120.00) […] - 2025-02-17 06:53:15
Yousif Capital Management LLC Decreases Stake in Haemonetics Co. (NYSE:HAE)
Yousif Capital Management LLC cut its position in Haemonetics Co. (NYSE:HAE – Free Report) by 6.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 18,274 shares of the medical instruments supplier’s stock after selling 1,224 shares during the period. Yousif […] - 2025-02-13 08:22:48
Analysts Set Haemonetics Co. (NYSE:HAE) PT at $101.67
Haemonetics Co. (NYSE:HAE – Get Free Report) has earned an average rating of “Moderate Buy” from the nine brokerages that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, six have assigned a buy recommendation and one has issued […] - 2025-02-12 06:10:43
JMP Securities Issues Pessimistic Forecast for Haemonetics (NYSE:HAE) Stock Price
Haemonetics (NYSE:HAE – Free Report) had its price objective decreased by JMP Securities from $125.00 to $100.00 in a research note released on Friday morning,Benzinga reports. JMP Securities currently has a market outperform rating on the medical instruments supplier’s stock. Other analysts have also issued research reports about the company. JPMorgan Chase & Co. initiated […] - 2025-02-10 18:38:21

HAE institutional holdings

The following institutional investment holdings of HAE have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 30,696USD 2,087,635
2025-05-08 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 41,626USD 2,830,984
2025-05-08 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 1,074USD 73,043
Total =73,396 USD 4,991,662
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.